WSTWest Pharmaceutical Services

$350.14

$230.7852 weeks$362.41

Price

$350.14+48%1Y

1M-1.3%1Y+48%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average

8/10

Value38

Quality86

Momentum69

Growth69

Strongest Quality, weakest Value · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services and integrated solutions.

In the company’s own words · 10-K filed Feb 17, 2026 · SEC EDGAR

P/E (TTM)46.8

Market Cap$23.17B

1Y Return+48%

5Y Return-14%

Business segments

Q1 2026 · $844.9M

The company’s own SEC segment disclosure.

Proprietary Products$694.3M82%
West Vantage$150.6M18%

West Pharmaceutical Services (WST) reported revenue of $845M in Q1 2026 (quarter ended March 31, 2026), up 21% from the same quarter a year earlier. That came with a gross margin of 35% and net income of $139M (16% of revenue). For the full year FY2025, revenue was $3.07B (+6.3% year on year) and net income $494M. Its largest segment in 2026-Q1 was Proprietary Products at $694M, 82% of the disclosed total, just ahead of West Vantage at 18%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.

Medical Instruments & Supplies

Ranks #4 of 27 by Smart Score

Cooper Companies (The)